Speaker(s): 

 Dr. Syeda Atiqa Batul- has nothing to disclose

Moderator(s): 

Anil Singh, MD, Staff Member, Geisinger - has nothing to disclose. 

Objectives:

  • Understand the epidemiology, pathophysiology and risk factors for sudden cardiac death (SCD).

  • Define the indications and limitations of wearable cardioverter defibrillators (WCDs).

  • Review the clinical evidence supporting the use of WCDs, patient selection criteria and consideration when prescribing WCDs.

  • Interactive case-based discussion of real-world scenarios with target audience to assess knowledge.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anil Kumar Singh, MD, Roop Parlapalli, MD, FHM, FACP, Lakshmi Rani Gollamudi, MD, Christopher DeFrancesco PharmD, RPH, Mary Ellen Berry, PA-C, and Carlena Miller, CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
12/19/2025 - 12:00pm to 1:00pm EST
Location: 
Geisinger Community Medical Center
1800 Mulberry Street
Scranton 18510
United States
  • 1.00 AAPA Category I CME
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.